Phase 2 trial of Oxford COVID-19 vaccine candidate set to begin https://ift.tt/eA8V8J

Serum Institute of India has partnered with British-Swedish pharma company AstraZeneca for manufacturing the COVID-19 vaccine candidate, developed by the University of Oxford.

from The Hindu - National https://ift.tt/2Exavsy